5 Leukemia Clinical Trials in Lincoln, NE (2026)

Q: How do I join a clinical trial in Lincoln?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Lincoln research site will contact you.

Recruiting Leukemia Studies in Lincoln

NCT07513376Recruiting

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

Researchers are looking for new ways to treat high-risk, localized non-small cell lung cancer (NSCLC) that has been removed with surgery. People with high-risk, localized NSCLC are often treated with...

Lincoln, NE876 participantsMerck Sharp & Dohme LLC

View Study Details

NCT07155187Recruiting

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is a common type of lung cancer where abnormal cells in the lungs grow out of control. The purpose of this study is to assess adverse events and change in disease ac...

Lincoln, NE490 participantsAbbVie

View Study Details

NCT07309432Recruiting

Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy

This study is researching 2 experimental drugs, REGN5713 and REGN5715. The study drugs will be either of these drugs given alone (either REGN5713 or REGN5715) or given together (REGN5713 and REGN5715)...

Lincoln, NE350 participantsRegeneron Pharmaceuticals

View Study Details

NCT07554339Recruiting

A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

Researchers are looking for new ways to treat locally advanced non-small cell lung cancer (NSCLC) that is unresected and has a gene mutation called KRAS G12C. Researchers want to learn if calderasib (...

Lincoln, NE310 participantsMerck Sharp & Dohme LLC

View Study Details

NCT07288177Recruiting

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

This Phase 2 study will be conducted in different countries around the world with up to about 240 participants. The purpose of this study is to evaluate how well Rina-S works against lung cancer. Th...

Lincoln, NE240 participantsGenmab

View Study Details

About Leukemia Clinical Trials in Lincoln

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 5 leukemia clinical trials recruiting participants in Lincoln, NE. These studies are seeking a combined 2,266 participants. Research is being sponsored by Merck Sharp & Dohme LLC, AbbVie, Regeneron Pharmaceuticals and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Lincoln — FAQ

Are there leukemia clinical trials in Lincoln?

Yes, there are 5 leukemia clinical trials currently recruiting in Lincoln, NE. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Lincoln?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lincoln research site will contact you about next steps.

Are clinical trials in Lincoln free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lincoln studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 5 active trials in Lincoln are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated July 13, 2026 from ClinicalTrials.gov